Show Summary Details
Page of

Acute rheumatic fever 

Acute rheumatic fever

Chapter:
Acute rheumatic fever
Author(s):

Jonathan R. Carapetis

DOI:
10.1093/med/9780199204854.003.160901_update_001

Update:

Diagnosis – 2014 revision of Jones criteria including (1) requirement for fever >38o, rather than >38.5o, in moderate-high risk populations; (2) echocardiographic features that allow the diagnosis of acute rheumatic carditis even in the absence of a significant cardiac murmur. Management – use of corticosteroids in severe or refractory chorea.

Updated on 29 Oct 2015. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 25 July 2017

Acute rheumatic fever is an immunologically mediated multisystem disease induced by recent infection with group A streptococcus. About 5% of people have the potential to develop acute rheumatic fever after infection by a strain of streptococcus with propensity to cause the condition. Most cases (97%) occur in low-income and some middle-income countries, with indigenous populations in some affluent countries also affected. Children aged 5 to 15 years are most commonly affected, and rheumatic heart disease remains the most common acquired heart disease of childhood in the world....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.